ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult your healthcare professional to see which product is right for you. For a list of compatible devices, please visit dexcom.com/compatibility. This product is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.

Diabetes never sleeps but now you can with Dexcom G6

Dexcom G6 is Now Subsidised!

The Australian Government offers access to subsidised CGM for Australians living with type 1 diabetes through the National Diabetes Services Scheme (NDSS) Initiative.

Trial offer_2402

Trial Dexcom G6 Now For $95!

For a limited time, the Dexcom G6 Trial Offer is available for $95 and provides you with 30 days of CGM use.

The limited-time Dexcom G6 Trial Offer includes the following:

  • 1 x Dexcom G6 Transmitter (3 month life and warranty from the date of activation)
  • 1 x box of Dexcom G6 Sensors (includes 3 x 10-day sensors)

This offer is available while stocks last and is subject to change without notice. Available to order once per customer and includes free shipping.

Introducing Dexcom G6

No Manual Scanning or Fingerpricks*

No Manual Scanning or Fingerpricks*

Manual scanning or fingerpricks* are not required to make treatment decisions.

*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Real-Time Glucose Readings

Real-Time Glucose Readings

Real-time readings, delivered automatically and discreetly to your phone or smart watch#

Dexcom G6 Family Image_small-1
Customisable Glucose Alerts

Customisable Glucose Alerts

Customisable glucose alerts, including the predictive Urgent Low Soon alert. Know before you’re low!

Outstanding, Reliable Accuracy⁶

Outstanding, Reliable Accuracy1

Have the confidence of precise glucose readings on your Dexcom app#

How Does Dexcom CGM Work?

 

Continuous Glucose Monitoring (CGM) is a diabetes management tool that measures glucose levels 24 hours a day using a sensor inserted just under the skin.


The device wirelessly transmits glucose readings every five minutes to a compatible smartphone, smart watch or Receiver.# It provides you with real-time interstitial glucose readings but can also alert you when your levels are too high or drop too low.

Sensor & Transmitter

Sensor & Transmitter

A slim sensor is inserted via an applicator and continuously measures glucose levels just beneath the skin, and sends data wirelessly via Bluetooth to a display device through a transmitter.

Display Device

Display Device

A compatible smart device or a small touchscreen Receiver displays real-time glucose readings#.

Dexcom G6 | Water Resistent

Rest Easy With Dexcom G6

  • Small and discreet wearable
  • Water resistant when swimming, showering or exercising±
  • Easier than ever to stay connected and customise what you share with your circle of support with Dexcom Follow

Who Can Benefit From A CGM System?

Anyone over two years of age with type 1, type 2 or gestational diabetes^ can benefit from CGM

Type 1 Diabetes

Type 1 diabetes

The Dexcom G6 helps type 1 diabetes management by providing the flexibility and convenience to monitor glucose data when, where and how you want.

Type 2 Diabetes

Type 2 diabetes

When you live with type 2 diabetes, caring for yourself is a 24/7 job that might feel overwhelming at times.
Dexcom CGM puts glucose data in the palm of your hand, so you can gain more control over your glucose levels,3,4 and get some extra peace of mind.

Gestational Diabetes

Gestational Diabetes

We know that being pregnant can be exhausting, but your diabetes management doesn’t need to be! With the help of Dexcom G6 CGM you can see and track your glucose levels at a glance.

It works whether you are using multiple daily injections (MDI) or an insulin pump.

Reduces HbA1c

Reduces HbA1c and increases time in range2-4

Reduces risk of hypoglycaemia

Reduces risk of hypoglycaemia6,7

Improves quality of life

Improves quality of life and well-being8

Want to Speak to a Dexcom Representative?

Leave your details below and we'll be in touch soon!

Looking for Technical Assistance? 

We offer 24/7 technical support to ensure you can always access help when you need it!

Speak to one of our technical support team members today. 

1300 851 056

diabetes@amsl.com.au

* If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
+ Dexcom G6 is compatible with the t:slim X2 insulin pump with Control -IQ technology.
** Smart device must have Bluetooth enabled
Eligibility criteria applies. Visit ndss.com.au/cgm for more details.
^This product is indicated for persons with diabetes mellitus age 2 years and older where SMBG is indicated.
# Connected compatible smart device required to display readings on smartwatch. Smart device and Receiver not included with Dexcom G6 CGM system. For a list of compatible devices, please visit dexcom.com/compatibility
Do not make treatment decisions based upon Share or Follow readings. Always confirm with your compatible smart device or Receiver. Internet connectivity required to access Dexcom Follow.
± The Dexcom G6 Sensor and Transmitter are water resistant and may be submerged under 2.4 metres of water for up to 24 hours without failure when properly installed.
$95 Trail Offer is available while stocks last and is subject to change without notice. Available to order once per customer and includes free shipping. For reference, sensor lasts 10 days, transmitter battery lasts 3 months. To continue after the 30 day trial period, patients will need to purchase further sensors (no further discount applies). Subsidised Dexcom CGM is available via the NDSS Subsidy Initiative for people living with type 1 diabetes. For more information, visit ndss.com.au/cgm

Dexcom, Dexcom G6, Dexcom Follow and Dexcom Share are registered trademarks of Dexcom, Inc. in the United States and/or other countries.

References: 1. 15 Diabetes Care. 2022;45(suppl 1):S232–S243. 2. Beck RW, et al. JAMA. 2017;317(4):371-378. 3. Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4. Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 5. Šoupal J, et al. Diabetes Technol Ther. 2016;18(9):532-8. 6. Heinemann L, et al. Lancet. 2018;391(10128):1367-1377. 7. Reddy M, et al. Diabet Med. 2018;35(4):483-490. 8. Lind M, et al. JAMA. 2017;317(4):379-387.

MAT-1218